Drug treatment for diabetes in nursing home residents

Diabetic Medicine

Volumn 31, Issue 5, 2014, Pages 570-576

  De Souto Barreto, P ^a,b   Sanz, C ^c,d   Vellas, B ^a,c   Lapeyre Mestre, M ^a,c   Rolland, Y ^a,c  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Faculté de Médecine Centre Hospitalo universitaire   (France)

^d CLINIQUE PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV; EXENDIN 4; GLUCOSE; INSULIN; METFORMIN; REPAGLINIDE; SITAGLIPTIN; SULFONYLUREA; VILDAGLIPTIN; ANTIDIABETIC AGENT;

AGED; ARTICLE; COMORBIDITY; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DECUBITUS; DIABETES MELLITUS; DISORIENTATION; DRUG USE; EMERGENCY WARD; FALLING; FEMALE; FRACTURE; FRANCE; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; NURSING HOME; NURSING HOME PATIENT; POLYPHARMACY; PRESCRIPTION; COMPLICATION; FOLLOW UP; FRACTURES, BONE; GERIATRIC ASSESSMENT; HYPOGLYCEMIA; INCIDENCE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VERY ELDERLY;

ACCIDENTAL FALLS; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; FRANCE; GERIATRIC ASSESSMENT; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; MALE; NURSING HOMES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84898901922     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12354     Document Type: Article

References (30)

1. Resnick HE, Foster GL. Diabetes in residential care facilities: United States, 2010. Diabetes Care 2013; 36: e37.
2. Resnick HE, Heineman J, Stone R, Shorr RI. Diabetes in US nursing homes, 2004. Diabetes Care 2008; 31: 287-288.
3. Zhang X, Decker FH, Luo H, Geiss LS, Pearson WS, Saaddine JB et al. Trends in the prevalence and comorbidities of diabetes mellitus in nursing home residents in the United States: 1995-2004. J Am Geriatr Soc 2010; 58: 724-730.
4. Moore KL, Boscardin WJ, Steinman MA, Schwartz JB. Age and sex variation in prevalence of chronic medical conditions in older residents of US nursing homes. J Am Geriatr Soc 2012; 60: 756-764.
5. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metrics 2010; 8: 29.
6. American Diabetes Association. Economic costs of diabetes in the US in 2012. Diabetes Care 2013; 36: 1033-1046.
7. Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med 2012; 29: 855-862.
8. Waldeyer R, Brinks R, Rathmann W, Giani G, Icks A. Projection of the burden of Type 2 diabetes mellitus in Germany: a demographic modelling approach to predict the direct medical excess costs from 2010 to 2040. Diabet Med 2013; 30: 999-1008.
9. Pickard L, Comas-Herrera A, Costa-Font J, Gori C, di Maio A, Patxot C et al. Modelling an entitlement to long-term care services for older people in Europe: projections for long-term care expenditure to 2050. J Eur Soc Policy 2007; 17: 33-48.
10. Rolland Y, de Souto Barreto P. Research can improve care in the nursing home. J Am Med Dir Assoc 2013; 14: 233-235.
11. De Souto Barreto P, Lapeyre-Mestre M, Mathieu C, Piau C, Bouget C, Cayla F et al. A multi-centric individually tailored controlled trial of education and professional support to nursing home staff: research protocol and baseline data of the IQUARE study. J Nutr Health Aging 2013; 17: 173-178.
12. Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P et al. Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci 2012; 67: 698-704.
13. Sjöblom P, Anders Tengblad, Löfgren U-B, Lannering C, Anderberg N, Rosenqvist U et al. Can diabetes medication be reduced in elderly patients? An observational study of diabetes drug withdrawal in nursing home patients with tight glycaemic control. Diabetes Res Clin Pract 2008; 82: 197-202.
14. Migdal A, Yarandi SS, Smiley D, Umpierrez GE. Update on diabetes in the elderly and in nursing home residents. J Am Med Dir Assoc 2011; 12: e2.
15. Garg R, Hurwitz S, Turchin A, Trivedi A. Hypoglycemia, with or without insulin therapy, is associated with increased mortality among hospitalized patients. Diabetes Care 2013; 36: 1107-1110.
16. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 2013; 36: 1384-1395.
17. Schwartz AV, Vittinghoff E, Sellmeyer DE, Feingold KR, de Rekeneire N, Strotmeyer ES et al. Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care 2008; 31: 391-396.
18. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011; 365: 2002-2012.
19. Meneilly GS, Cheung E, Tuokko H. Counter-regulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes 1994; 43: 403-410.
20. Matyka K, Evans M, Lomas J, Cranston I, Macdonald I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 1997; 20: 135-141.
21. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001; 125: 279-284.
22. Feldman SM, Rosen R, DeStasio J. Status of diabetes management in the nursing home setting in 2008: a retrospective chart review and epidemiology study of diabetic nursing home residents and nursing home initiatives in diabetes management. J Am Med Dir Assoc 2009; 10: 354-360.
23. Pandya N, Thompson S, Sambamoorthi U. The prevalence and persistence of sliding scale insulin use among newly admitted elderly nursing home residents with diabetes mellitus. J Am Med Dir Assoc 2008; 9: 663-669.
24. Gadsby R, Galloway M, Barker P, Sinclair A. Prescribed medicines for elderly frail people with diabetes resident in nursing homes-issues of polypharmacy and medication costs. Diabet Med 2012; 29: 136-139.
25. Maurer MS, Burcham J, Cheng H. Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility. J Gerontol A Biol Sci Med Sci 2005; 60: 1157-1162.
26. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013; 36: S11-66.
27. Antithrombotic Trialists' (ATT) Collaboration; Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849-1860.
28. Roussel R, Travert F, Pasquet B, Wilson PW, Smith SC Jr, Goto S et al. Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med 2010; 170: 1892-1899.
29. Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A et al. Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis. Diabetes Obes Metab 2012; 14: 803-809.
30. Saenz A, Fernandez-Esteban I, Mataix A, Ausejo M, Roque M, Moher D. Metforminmonotherapy for type 2 diabetes mellitus. Cochrane Database Syst Rev 2005; 3: CD002966.